Overview for Biologics GxP Applications
Regulatory requirements necessitate that biologics drug products be QC tested using methods that are robust and have been appropriately developed, qualified, and validated under GMP conditions. Among these assays, titer measurement for potency assessment and ligand binding kinetics assays are increasingly being used for biological products' lot release. Drug developers are constantly in search of analytical technologies with robust features that are easy to use and adaptable in QC and manufacturing.
-
Ligand binding potency assays on the Octet platform
Reproducible and accurate relative ligand binding potency methods can be developed using analytical technologies. These methods can be used to asses lot-to-lot variability by monitoring either the kinetics of binding or by comparing affinity constants. They can also be used to determine the stability of the different lots of the drug, hence the method has to indicate stability. Due to their ease of use and fast time to results, real-time label-free analytical techniques are increasingly becoming attractive for the development of methods for assessing the potency of drug candidates.
- Readily accommodates the use of DOEs to rapidly develop robust potency measurement methods
- Develops relative affinity constant or response signals comparability studies for potency measurements
Ligand binding potency assays on the Octet platform
Reproducible and accurate relative ligand binding potency methods can be developed using analytical technologies. These methods can be used to asses lot-to-lot variability by monitoring either the kinetics of binding or by comparing affinity constants. They can also be used to determine the stability of the different lots of the drug, hence the method has to indicate stability. Due to their ease of use and fast time to results, real-time label-free analytical techniques are increasingly becoming attractive for the development of methods for assessing the potency of drug candidates.
- Readily accommodates the use of DOEs to rapidly develop robust potency measurement methods
- Develops relative affinity constant or response signals comparability studies for potency measurements
Fc receptor binding assays on the Octet system
The safety and efficacy of a therapeutic monoclonal antibody can be greatly impacted by its ability to bind to both the target and to the FcγR. Antibodies are often selected based on their binding properties to FcγRs. They are sometimes engineered to achieve desired FcγRs binding properties. As a result, the assessment of binding affinities of these antibodies to FcγRs is an integral part of biotherapeutic development processes.
- Octet systems offer high throughput and sensitive methods for Fc receptor binding analysis
- A variety of biosensor surfaces are available and allow for flexibility and rapid optimization of assay format
Fc receptor binding assays on the Octet system
The safety and efficacy of a therapeutic monoclonal antibody can be greatly impacted by its ability to bind to both the target and to the FcγR. Antibodies are often selected based on their binding properties to FcγRs. They are sometimes engineered to achieve desired FcγRs binding properties. As a result, the assessment of binding affinities of these antibodies to FcγRs is an integral part of biotherapeutic development processes.
- Octet systems offer high throughput and sensitive methods for Fc receptor binding analysis
- A variety of biosensor surfaces are available and allow for flexibility and rapid optimization of assay format
-
Titer determination on the Octet platform
Titer and protein concentration determination is a critical process in the development of biologics drug molecules. The active protein concentration can be used to determine the potency of the drug molecule. While ELISA and especially HPLC are commonplace techniques for titer and protein concentration determination, techniques that are more robust to cell culture and media are especially desirable as they can be easily adopted in both upstream and downstream processes during the development of the drug molecule.
- A full plate (96 samples) of IgG titer can be analyzed in as little as two minutes
- Sample plate format allows for the use of crude and non-purified samples
- Automation capable Octet HTX and Red 384 allow for walkaway high throughput analysis
Titer determination on the Octet platform
Titer and protein concentration determination is a critical process in the development of biologics drug molecules. The active protein concentration can be used to determine the potency of the drug molecule. While ELISA and especially HPLC are commonplace techniques for titer and protein concentration determination, techniques that are more robust to cell culture and media are especially desirable as they can be easily adopted in both upstream and downstream processes during the development of the drug molecule.
- A full plate (96 samples) of IgG titer can be analyzed in as little as two minutes
- Sample plate format allows for the use of crude and non-purified samples
- Automation capable Octet HTX and Red 384 allow for walkaway high throughput analysis
Resources for Biologics GxP Applications
Application Note
Analysis of FcRn-Antibody Interactions on the Octet Platform
Analysis of FcRn-Antibody Interactions on the Octet Platform
The Fc region of human IgG contributes to a number of beneficial biological and pharmacological characteristics of therapeutic antibodies. One of the most important is prolonging plasma…
-
Application Note
Analysis of Fc-gamma Receptor-IgG Interactions on the Octet Platform
Analysis of Fc-gamma Receptor-IgG Interactions on the Octet Platform
Fc gamma receptors (FcγRs) are membrane glycoproteins with affinity for the Fc region of immunoglobulin G (IgG). FcγRs expressed on the surface of immune effector cells play a key role in…
-
Application Note
Validated Quantitation and Activity Assay of Antibody Fragment Molecule (Fab) for Process Development and Quality Control
Validated Quantitation and Activity Assay of Antibody Fragment Molecule (Fab) for Process Development and Quality Control
The group was able to develop a working Fab activity assay on the Octet RED system in less than a week. Relative to the overnight incubation and four-hour assay time of their ELISA protocol…
-
Application Note
Octet Potency Assay: Development, Qualification and Validation Strategies
Octet Potency Assay: Development, Qualification and Validation Strategies
Kinetic analysis of biomolecular interactions is critical during drug discovery and development. The affinity of an interaction directly affects the dose required for a biopharmaceutical to…
-
Application Note
Enhancing Efficiency and Economics in Process Development and Manufacturing of Biotherapeutics
Enhancing Efficiency and Economics in Process Development and Manufacturing of Biotherapeutics
Analytical techniques that measure protein quantity and quality are used in nearly all stages of research, process development and manufacturing of biotherapeutics. UV spectroscopy, ELISA…
Publications
A Detection and Quantification Label-free Tool to Speed Up Downstream Processing of Model Mucins
A Detection and Quantification Label-free Tool to Speed Up Downstream Processing of Model Mucins
Mucins are high-molecular weight glycoproteins secreted by epithelial cells. Recent studies have linked mucins to a variety of inflammatory diseases and cancer, suggesting them to be good th…
-
Publications
Attaining Next-Level Titers in CHO Fed-Batch Cultures
Attaining Next-Level Titers in CHO Fed-Batch Cultures
There are inherent difficulties in providing desired concentrations of critical nutritional components in fed-batch cultures. The authors describe a new functional additive that is highly co…
-
Publications
GlycoDelete Engineering of Mammalian Cells Simplifies N-glycosylation of Recombinant Proteins
GlycoDelete Engineering of Mammalian Cells Simplifies N-glycosylation of Recombinant Proteins
This report described a new methodology called GlycoDelete, a glycoengineering strategy used as an approach to solve the issues of N-glycosylation heterogeneity in mammalian cell-based glyco…
Ready to get started?
We are ready to help you solve your tough research challenges. Our proven solutions and highly qualified teams across the globe can help advance your next big discovery.